Dudediligence.

Exicure, Inc

XCURNASDAQ · Pharmaceutical Preparations
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

6.37M

on 2026-06-30, from 2.17M on 2024-09-30 10-Q ↗

Counts before 2024-09-30 are left out: the count went from 8.65M on 2024-06-30 to 2.17M on 2024-09-30, a change no split on file explains.

a raise that quarter, at its price

Newest

None

No S-3 or F-3 shelf on file in the last 30 months.

4 of its filings are not read yet.

Warrants

None

Priced warrants: none left. 10-K ↗

Cash

1 quarters

$1.7M on 2026-06-30 ÷ $1.7M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
DateWhatSharesPriceGrossFiling
2024-12-11Private placementnot read$4.61$2.0M8-K ↗
2024-11-14Private placementnot read$3.00$1.3M8-K ↗